Antibiotic resistance of Helicobacter pylori in Nanjing, China: a cross-section study from 2018 to 2023

Antibiotic resistance of Helicobacter pylori in Nanjing, China: a cross-section study from 2018 to 2023

BackgroundThe increasing prevalence of antibiotic resistance in cases of Helicobacter pylori (H. pylori) infection has emerged as a significant global issue. This study offers a comprehensive examination of the alterations in drug resistance exhibited by H. pylori in the Nanjing region of China duri...

Full description

Bibliographic Details
Main Authors:	Wenjuan Wei, Zhibing Wang, Chao Li, Zongdan Jiang, Zhenyu Zhang, Shukui Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Helicobacter pylori antibiotics resistance levofloxacin PCR gyrA mutations
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1294379/full

Similar Items

Current status of Helicobacter pylori resistance to clarithromycin and levofloxacin in Vietnam: Results from molecular analysis of gastric biopsy specimens
by: Van Huy Tran, et al.
Published: (2024-03-01)

Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021
by: Zongdan Jiang, et al.
Published: (2022-09-01)

Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing
by: Toshihiro eNishizawa, et al.
Published: (2014-10-01)

Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia—findings from a molecular based study
by: Suat Moi Puah, et al.
Published: (2021-06-01)

Rapid Detection of Quinolone Resistance Mutations in <i>gyrA</i> of <i>Helicobacter pylori</i> by Real-Time PCR
by: Franziska Haumaier, et al.
Published: (2022-01-01)

Molecular characterization and prevalence of antibiotic resistance in Helicobacter pylori isolates in Kuala Lumpur, Malaysia
by: Hanafiah A, et al.
Published: (2019-09-01)

The Efficacy of Levofloxacin versus Clarithromycin in Primary Quadruple Therapy for the Eradication of Helicobacter Pylori: A Prospective Randomized Controlled Clinical Trial Study
by: Vahid Sebghatollahi, et al.
Published: (2020-06-01)

Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
by: Konrad Egli, et al.
Published: (2020-12-01)

Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey
by: Reyhan Caliskan, et al.
Published: (2015-06-01)

Primary antibiotic resistance and associated mechanisms in <it>Helicobacter pylori</it> isolates from Senegalese patients
by: Seck Abdoulaye, et al.
Published: (2013-01-01)

Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing
by: Lok CH, et al.
Published: (2020-07-01)

Comparing Clarithromycin- and Levofloxacin-Containing Triple Therapies for First Line Helicobacter pylori Eradication in Mazandran Province, Iran
by: Sepehr Tirgar Fakheri, et al.
Published: (2019-09-01)

Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy
by: Binmaeil H, et al.
Published: (2021-10-01)

Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy [Corrigendum]
by: Binmaeil H, et al.
Published: (2023-07-01)

Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial
by: Vahid Sebghatollahi, et al.
Published: (2018-01-01)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01)

Characteristics of Helicobacter pylori Heteroresistance in Gastric Biopsies and Its Clinical Relevance
by: You-hua Wang, et al.
Published: (2022-02-01)

Whole-Genome Sequencing and Bioinformatics as Pertinent Tools to Support Helicobacteracae Taxonomy, Based on Three Strains Suspected to Belong to Novel Helicobacter Species
by: Elvire Berthenet, et al.
Published: (2019-12-01)

Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
by: Yangxia Li, et al.
Published: (2020-07-01)

Twelve-day quintuple regime containing four antibiotics as a rescue therapy for Helicobacter pylori eradication in the central region of Portugal
by: Diogo Branquinho, et al.

Antimicrobial resistance of Helicobacter pylori in Smolensk
by: Dekhnich N.N., et al.
Published: (2018-02-01)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
by: Eman T. Azab, et al.
Published: (2022-06-01)

Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus
by: Mohammad Arjomandzadegan, et al.
Published: (2016-01-01)

Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis
by: Masoud Keikha, et al.
Published: (2022-06-01)

Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice
by: Hyung Min Noh, et al.
Published: (2016-11-01)

Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis
by: Min Qiao, et al.
Published: (2021-05-01)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
by: Tariq H, et al.
Published: (2020-01-01)

Surveillance of Helicobacter pylori resistance over 22 Years (2000-2021) in Northern Spain
by: Marta Gómez-Ruiz de Arbulo, et al.
Published: (2023-09-01)

Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori Eficacia de una triple terapia con un inhibidor de la bomba de protones, levofloxacino y amoxicilina, como primer tratamiento, en la erradicación de Helicobacter pylori
by: M. Castro-Fernández, et al.
Published: (2009-06-01)

Current development of <i>Helicobacter pylori</i> eradication protocols
by: A. O. Pozdeeva, et al.
Published: (2022-01-01)

Comparison of the effect of levofloxacin-based three-drug regimen with clarithromycin-based four-drug regimen in the treatment of Helicobacter pylori infection in Birjand: Short Communication
by: Fatemeh Abasnia, et al.
Published: (2021-06-01)

Detection of fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates as determined by gyrA/B gene mutation by using PCR technique
by: A. Salah Eldin, et al.
Published: (2012-10-01)

Clarithromycin versus levofloxacin-based regimens for Helicobacter pylori eradication in the Kurdistan Region of Iraq: A randomized clinical trial
by: Shinah A. Mohammed, et al.
Published: (2019-09-01)

Molecular Detection of gyrA Mutation in Clinical Strains of Klebsiella pneumoniae
by: Zeinab Ahmadi, et al.
Published: (2022-10-01)

First report of molecular detection of fluoroquinolone resistance-associated <it>gyrA </it>mutations in multidrug-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
by: Ahmad Suhail, et al.
Published: (2011-04-01)

Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study
by: Mengqiu Xiong, et al.
Published: (2023-10-01)

Use of a MAMA-PCR Method to detect gyrA Mutations in Nalidixic Acid-Resistant Clinical Isolates of Escherichia coli
by: A Karami, et al.
Published: (2008-05-01)

Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in <i>Helicobacter pylori</i> from Gastric Biopsies in Southern Croatia
by: Ivica Šamanić, et al.
Published: (2023-09-01)

Molecular and proteomic analysis of levofloxacin and metronidazole resistant Helicobacter pylori
by: Aimi Hanafi, et al.
Published: (2016-12-01)

Therapeutic efficacy and drug safety comparison of one-week Vonoprazan triple therapy with two-weeks Esomeprazole triple therapy in Helicobacter pylori infection: Findings from a single-centre randomized clinical trial in population of Pakistan
by: Farzana Waqar, et al.
Published: (2024-02-01)